MAIA Biotechnology, Inc. 8-K

What Happened
MAIA Biotechnology, Inc. announced on January 13, 2026 that it filed a Current Report on Form 8-K under Regulation FD to disclose presentation materials its management intends to use, including at the Biotech Showcase in San Francisco on January 13, 2026. The Presentation Materials were filed as Exhibit 99.1 to the 8-K and posted the same day on the company website (www.maiabiotech.com). The materials include forward-looking statements.

Key Details

• Form 8-K filed: January 13, 2026 (Regulation FD disclosure, Item 7.01).
• Presentation used at: Biotech Showcase, San Francisco, CA on January 13, 2026.
• Exhibit filed: Presentation Materials (Exhibit 99.1) and posted on MAIA’s website.
• Disclosure notes: Presentation contains forward‑looking statements; investors are cautioned not to place undue reliance on them.

Why It Matters
This 8-K is a routine Regulation FD disclosure that makes the company’s investor presentation publicly available so all investors have equal access to the same information. It is not a financial report (no earnings or executive changes were announced). Investors should review the posted presentation for any program updates or guidance and keep in mind the forward‑looking nature of some statements.